circRNA basic information
circBase ID: hsa_circ_0001610
Name: hsa_circ_TNFRSF21
Synonym: hsa_-circ_0001610
Host Gene: TNFRSF21
Genomic location(hg19): chr6:47251673-47254331:-
Genomic location(hg38): chr6:47283937-47286595:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007254
MONDO name: breast cancer
Disease details: breast cancer
Disease DO ID:
1612
Disease MeSH ID:
-
Disease NCIt ID:
C9335
Disease ICD11 ID:
1047754165
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

tumor samples; tumor tissues; xenografted tumors

Cell lines:

MCF-10A; MCF-7; BT-549; MDA-MB-468; MDA-MB-231; 293T

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: SLC7A11 mRNA, SLC7A11
Associated microRNA: miR-139-5p
Biological function: hsa_circ_0001610 reduces the radiosensitivity of breast cancer cells, promotes cell viability, colony formation, invasion and migration after irradiation, reduces apoptosis and G2/M arrest, and counteracts DHA-induced ferroptosis.
Molecular mechanism: hsa_circ_0001610 acts as a molecular sponge for miR-139-5p, increases SLC7A11 expression, suppresses ferroptosis, and thereby reduces radiosensitivity; DHA downregulates hsa_circ_0001610 and suppresses the hsa_circ_0001610/miR-139-5p/SLC7A11 pathway.
Biological pathway or process:

ferroptosis (inhibits); radioresistance (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); cell cycle (other); ceRNA regulation (other)

Detected method:
Q
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; RT-qPCR; FISH / smFISH; Bioinformatics Analysis; Luciferase Reporter Assay; RNA Pull-Down; Transfection; CCK8; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Flow Cytometry(Non-apoptosis/cycle); Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); H&E Staining

Clinical significance:

hsa_circ_0001610 was suggested as a potential biomarker and therapeutic target for breast cancer radiosensitivity.

Description:

In this study, hsa_circ_0001610 is upregulated in irradiated breast cancer cells and functions as a radioresistance-associated circRNA. It acts as a miR-139-5p sponge to increase SLC7A11 expression and suppress ferroptosis, while DHA downregulates hsa_circ_0001610 to enhance ferroptosis and radiosensitivity.

Confidence score:

0.8279

Other information
Title:

Dihydroartemisinin enhances the radiosensitivity of breast cancer by targeting ferroptosis signaling pathway through hsa_circ_0001610.

Journal: European journal of pharmacology
Published: 2024
PubMed ID: 39182549
Study type:

biological research

Data availability: Data will be made available on request; Supplementary data to this article can be found online at https://doi.org/10.1016/j.ejphar.2024.176943.
Code availability: -